Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
"Special Situation"-Aktie mit Multi-Tenbagger-Potenzial im heißesten Rohstoff-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
17 Leser
Artikel bewerten:
(0)

U.S. POC/Decentralized Diagnostic Testing Market 2016: Supplier Shares, Volume and Sales Forecasts for 300 Tests, Emerging Technologies, Competitive Strategies

DUBLIN, Nov. 20, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/kp2tnc/2016_u_s) has announced the addition of the "2016 U.S. POC/Decentralized Diagnostic Testing Market: Supplier Shares, Volume and Sales Forecasts for 300 Tests, Emerging Technologies, Competitive Strategies" report to their offering.

This new 1,172-page report contains 256 tables, and provides a comprehensive analysis of the10 major POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis

- Review of the10 major POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.

Five-year test volume and reagent sales forecasts for over 300 chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures by market segment:

- Home/Personal Testing - Physician Offices/Group Practices - Emergency Rooms - Operating/Recovery Suites - ICUs/CCUs - Cancer Clinics - Ambulatory Care Centers - Surgery Centers - Nursing Homes - Birth Centers

By test category:

- Routine and Special Chemistry - Microbiology/Infectious Diseases - Hematology - Flow Cytometry - Coagulation - Immunoproteins - Drugs of Abuse - TDM - Endocrine Function - Tumor Markers

Competitive Assessments

- Abbott- ADI/American Diagnostica/Sekisui- Agilent Technologies- Alere/Biosite/Inverness- Axis-Shield- Beckman Coulter/Danaher- Becton Dickinson- Bio/Data- Biomerieux- Bio-Rad- Cepheid- Diamedix- Diasorin- Eiken Chemical- EKF Diagnostics- Fujirebio- Grifols- Helena Laboratories- Horiba- Instrumentation Laboratory- Kreatech/Leica- Kyowa Medex- Lonza- Mackay Life Sciences- Matritech- Nihon Kohden- Polartechnics- Polymedco- Qiagen- Roche- Tosoh- Wako- Zycare/Alere

For more information visit http://www.researchandmarkets.com/research/kp2tnc/2016_u_s

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.